Recent research has reported significant elevations of IL-26 in individuals with different inflammatory conditions, including rheumatoid arthritis, Behçet’s disease, atopic dermatitis, psoriasis, asthma, and inflammatory bowel disease, indicating its multifaceted roles in antiviral, antimicrobial, and autoimmune responses (Meller et al., 2015; Stephen-Victor et al., 2016). Here, IL26 is linked to inflammatory bowel disease.